Subscribe to MedHeadlinesNews FeedSubscribe to MedHeadlinesComments

Amgen’s NPLATE Effective, but Not Without Risks

March 10, 2008 by MedHeadlines  
Filed under Autoimmune Diseases, Drugs, FDA

6 Comments

The Food and Drug Administration (FDA) panel will vote Wednesday on whether Amgen’s drug, NPLATE, provides enough benefit to counteract the side effects associated with its use. NPLATE is intended to treat Idiopathic Thrombocytopenic Purpura (ITP), an autoimmune disorder characterized by very low levels of platelets leading to uncontrolled bleeding. Read more

Tags: , ,

-->

Polls

  • In your opinion, should alternative medicine be regulated by the government?

    View Results

    Loading ... Loading ...

Editor's Picks

alt text Hope for Mesothelioma Patients May Lie in Recent Genetic Study

A recently published article about the genetic affect of asbestos exposure has offered...

alt text Women Dying To Be Beautiful?

If researchers are right, it may be more than mere coincidence that beauty and pain...

alt text The Cause of Mesothelioma Could be in Your Attic

With energy prices on the rise, homeowners are looking for ways to improve heating...

More Editor's Picks
    End, comment out -->

NEWS CATEGORIES